I-Derm Pharma

First-in-Class Oral Therapy for Inflammatory Autoimmune Skin Diseases

Active Pre-Seed Startup Nazareth Founded 2022-01

Website ↗

I-Derm Pharma is developing a first-in-class oral therapy for moderate-to-severe psoriasis. Our proprietary small-molecule family targets an inflammatory pathway and has shown strong preclinical efficacy in chimeric mice with psoriatic human skin grafts, alongside a favorable safety profile. We are advancing our lead candidate toward IND with robust IP and…